2XP2: Structure Of The Human Anaplastic Lymphoma Kinase In Complex Crizotinib (Pf-02341066)
reference: Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal-Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK)., Cui JJ, Tran-Dube M, Shen H, Nambu M, Kung PP, Pairish M, Jia L, Meng J, Funk L, Botrous I, McTigue M, Grodsky N, Ryan K, Padrique E, Alton G, Timofeevski S, Yamazaki S, Li Q, Zou H, Christensen J, Mroczkowski B, Bender S, Kania RS, Edwards MP, J Med Chem. 2011 Sep 22;54(18):6342-6363. Epub 2011 Aug 18. PMID: 21812414

This OCA Structure page
uses Jmol, developed by the Jmol Development Team (documentation).